About 200 reports

  • Dementia
  • DEMENTIA
  • Dementia
  • Allergan plc
  • Eisai Co., Ltd.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • United States Dementia Market Outlook
  • Australia Dementia Market Outlook
  • Dementia
  • Axovant Sciences Ltd.
  • Biotie Therapies Corp.
  • Novartis AG
  • Pfizer Inc.
  • FEATURES OF VASCULAR DEMENTIA PATIENTS
  • Prevalence of Vascular Dementia, males (000s)
  • Dementia
  • Mental Health
  • Pathology
  • Asia
  • Europe

Vascular Dementia - Epidemiology Forecast to 2027 ##.

  • Dementia
  • France
  • Germany
  • Italy
  • Spain

Vascular Dementia : ##MM Market Analysis ##. ##. ##MM Market Size of Vascular Dementia ##. ##. ##MM Percentage Share of drugs marketed for Vascular Dementia ##. ##. ##MM Market Sales of Vascular Dementia by Products ##.

  • Dementia
  • France
  • Germany
  • Italy
  • Spain
  • Alzheimer's disease in 2016, and the patients diagnosed with Alzheimer's or another dementia
  • Alzheimer's and other dementias, including blood vessel damage and genetic risk
  • Dementia
  • Biogen Idec Inc.
  • Eisai Co., Ltd.
  • Eli Lilly & Co.
  • Roche Group
  • DSM-IV Criteria for the Diagnosis of Dementia
  • 4.1 BIBLIOGRAPHY
  • Dementia
  • Italy
  • Japan
  • Spain
  • Forecast

The treatment for syndromes of dementia and movement disorders market is categorized on the basis of the drugs used to treat progressive dementia, drugs used to treat progressive dementia with neurological abnormalities, drugs used to treat movement disorder syndromes, and

  • Dementia
  • Mental Health
  • World
  • Company Financials
  • Market Size
  • 1.1.2 Types of Dementia
  • 2.1 Global Dementia Market
  • Dementia
  • Eli Lilly & Co.
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • EXELON
  • EISAI PHARMACEUTICALS

These drugs are indicated for the treatment of dementia associated with Alzheimer' s disease, but they do not treat the underlying cause of dementia.

  • Dementia
  • Forecast
  • Allergan plc
  • Eisai Co., Ltd.
  • Novartis AG
  • 6.1.1 PROBABLE AD DEMENTIA
  • DSM-IV CRITERIA FOR THE DIAGNOSIS OF DEMENTIA
  • Dementia
  • Allergan plc
  • Biogen Idec Inc.
  • Eisai Co., Ltd.
  • Novartis AG
  • 2.1.5 MULTIPLE SCLEROSIS
  • NEURODEGENERATIVE DISORDERS THERAPEUTICS MARKET, COMORBIDITIES ASSOCIATED WITH

Dementia: Hope Through Research.

  • Dementia
  • World
  • Biogen Idec Inc.
  • Novartis AG
  • Roche Group

Alzheimer's disease

4546 5000 3864
  • DEMENTIA CAREGIVER TASKS
  • DRUG TREATMENT RATES FOR ALZHEIMER'S DISEASE DEMENTIA ALSO VARY ACCORDING TO COUNTRY
  • Dementia
  • Asia
  • Europe
  • Japan
  • World
  • 10.1.4 Types of Dementia
  • Untitled
  • Dementia
  • Biogen Idec Inc.
  • Merck Serono S.A.
  • Novartis AG
  • Pfizer Inc.
  • 5.1.1 PROBABLE AD DEMENTIA
  • DSM-III-R CRITERIA FOR THE DIAGNOSIS OF DEMENTIA
  • Dementia
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • CAUSE OF THE DISEASE
  • INTRODUCTION
  • Dementia
  • Mental Health
  • Pathology
  • Europe
  • AD Market, Global Deterioration Scale for AD
  • AD Market, Symptoms of AD at Different Stages of Disease
  • Dementia
  • Asia
  • World
  • Forecast
  • Biogen Idec Inc.
  • Nicergoline Major Producer and Their Market Share
  • Overview
  • Dementia
  • China
  • Demand
  • Janssen Biotech, Inc.
  • Xian-Janssen Pharmaceutical Ltd.
  • Alzheimer's Disease Therapeutics Market, Global Deterioration Scale for
  • 2.5 Pathophysiology
  • Dementia
  • World
  • Forecast
  • Market Size
  • Eisai Co., Ltd.
  • Prevalence of dementia in sporadic ALS patients, total (000s)
  • Prevalence of dementia by type in sporadic ALS, total (000s)
  • Dementia
  • Mental Health
  • Europe
  • Nicergoline Major Producer and Their Market Share
  • Overview
  • Dementia
  • China
  • Guizhou Yibai Pharmaceutical Co., Ltd.
  • Novartis AG
  • Shandong Qilu Pharmaceutical Co., Ltd
  • Lewy body Dementia - Dormant Projects
  • Lewy body Dementia - Therapeutics Assessment
  • Dementia
  • United States
  • World
  • Product Initiative
  • Axovant Sciences Ltd.

DEMENTIA OCCURS AS A RESULT OF CHANGES IN THE BRAIN THAT AFFECT A PERSON' S ABILITY TO THINK AND REMEMBER.

  • Dementia
  • China
  • Trade
  • AstraZeneca China Inc.
  • Beijing Sihuan Pharmaceutical Co., Ltd.
  • LEWY BODY DEMENTIA THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2017*
  • Clinical Trial profile. 26 Trial Title
  • Clinical Trial
  • Dementia
  • Neurology
  • Therapy
  • Yt Blood Group
  • Plants And Their Constituents With Relevance For Dementia: Disease Prevention
  • Global Trajectory of Dementia Patients (Million): 2013--2050
  • Dementia
  • United States
  • World
  • Cowen & Co., LLC
  • Pfizer Inc.
  • TOP COMPANIES PARTICIPATING IN DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE THERAPEUTICS CLINICAL TRIALS
  • LATEST CLINICAL TRIALS NEWS ON DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE
  • Dementia
  • Drug Discovery And Development
  • World
  • Product Initiative
  • Yt Blood Group

Dementia UK French Economic Committee King’s College London Ministry of Health, Labout and Welfare (MHLW) (Japan) National Health Services (Italy) National Health Services (NHS) (UK) National Institute of Clinical Excellence (NICE) National Institute of Health (NIH) The Alzheimer’s Associat

  • Dementia
  • Diagnostics
  • Mental Health
  • Pathology
  • Market Size

DEMENTIA OCCURS AS A RESULT OF CHANGES IN THE BRAIN THAT AFFECT A PERSON' S ABILITY TO THINK AND REMEMBER.

  • Dementia
  • China
  • Demand
  • Market Size
  • Trade
  • LEWY BODY DEMENTIA - DORMANT PROJECTS, H1 2016
  • Lewy body Dementia - Product Development Milestones
  • Dementia
  • United States
  • World
  • Product Initiative
  • Axovant Sciences Ltd.
  • AIDS Associated Dementia Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • AIDS Associated Dementia Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Dementia
  • HIV AIDS
  • Neurology
  • World
  • Product Initiative